Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» COPD
COPD
FDA approves Trelegy Ellipta as once-daily single inhaler triple therapy for asthma and COPD
FDA approves Trelegy Ellipta as once-daily single inhaler triple therapy for asthma and COPD
Pharmaceutical Business Review
GSK
Innovia
Trelegy Ellipta
COPD
asthma
FDA
Flag link:
Verona to test COPD hopeful ensifentrine in COVID-19 patients
Verona to test COPD hopeful ensifentrine in COVID-19 patients
Pharmaforum
Verona Pharma
COVID-19
COPD
ensifentrine
Flag link:
GSK’s latest pipeline review includes a slate of COPD programs headed to the scrap heap
GSK’s latest pipeline review includes a slate of COPD programs headed to the scrap heap
Endpoints
GSK
R&D
COPD
HIV
cancer
Flag link:
AstraZeneca COPD drug finally gets OK from FDA, inching closer to GSK leader
AstraZeneca COPD drug finally gets OK from FDA, inching closer to GSK leader
Endpoints
AstraZeneca
COPD
FDA
Breztri Aerosphere
PT010
GSK
Trelegy
Flag link:
Teva launches digital asthma and COPD rescue inhaler in US
Teva launches digital asthma and COPD rescue inhaler in US
Pharmaforum
Teva Pharmaceutical
digital inhaler
asthma
COPD
rescue inhaler
ProAir Digihaler
Flag link:
AstraZeneca touts triplet inhaler Breztri's COPD win ahead of key FDA decision
AstraZeneca touts triplet inhaler Breztri's COPD win ahead of key FDA decision
Fierce Pharma
AstraZeneca
COPD
Breztri
clinical trials
Flag link:
PT010 significantly reduced rate of moderate or severe COPD exacerbations in ETHOS trial
PT010 significantly reduced rate of moderate or severe COPD exacerbations in ETHOS trial
Pharmaceutical Business Review
AstraZeneca
PT010
COPD
clinical trials
Flag link:
Kaia Health plans expansion into virtual care for COPD with $26M in new funding
Kaia Health plans expansion into virtual care for COPD with $26M in new funding
MedCity News
Kaia Health
startup
digital health
COPD
funding
virtual care
Flag link:
Propeller Health gets nod for use of sensor, app product with AstraZeneca inhaler
Propeller Health gets nod for use of sensor, app product with AstraZeneca inhaler
MedCity News
FDA
AstraZeneca
Propeller Health
devices
inhalers
Symbicort
asthma
COPD
Flag link:
AstraZeneca tackles COPD, asthma patients' COVID-19 concerns in new YouTube series
AstraZeneca tackles COPD, asthma patients' COVID-19 concerns in new YouTube series
Fierce Pharma
AstraZeneca
YouTube
COPD
asthma
coronavirus
COVID-19
Flag link:
A bruised Circassia offloads debt by returning COPD drugs to AstraZeneca
A bruised Circassia offloads debt by returning COPD drugs to AstraZeneca
Endpoints
Circassia
AstraZeneca
COPD
Flag link:
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round
Fierce Pharma
Perrigo
Catalent
Teva Pharmaceutical
ProAir HFA
asthma
COPD
generics
Flag link:
FDA's Advisory Committee to Review Claims That GlaxoSmithKline's Trelegy Ellipta Reduces Mortality
FDA's Advisory Committee to Review Claims That GlaxoSmithKline's Trelegy Ellipta Reduces Mortality
Motley Fool
GSK
FDA
advisory panels
COPD
Trelegy Ellipta
Flag link:
AstraZeneca expanding again in Australia, pledging $133M investment at Sydney site and adding 250 jobs
AstraZeneca expanding again in Australia, pledging $133M investment at Sydney site and adding 250 jobs
Fierce Pharma
AstraZeneca
Australia
New Zealand
drug manufacturing
asthma
COPD
Flag link:
Chasing Mylan, Hikma tries again with rejected generic Advair in US
Chasing Mylan, Hikma tries again with rejected generic Advair in US
Pharmaforum
Hikma
FDA
generics
GSK
Advair
asthma
COPD
Flag link:
GlaxoSmithKline leans on respiratory franchise with Trelegy share-grab
GlaxoSmithKline leans on respiratory franchise with Trelegy share-grab
Fierce Pharma
GSK
Trelegy Ellipta
COPD
Flag link:
AstraZeneca's combo lung disease therapy fails to win FDA approval
AstraZeneca's combo lung disease therapy fails to win FDA approval
Reuters
AstraZeneca
FDA
COPD
PT010
Flag link:
AstraZeneca respiratory business gets boost from 3-drug inhaler results
AstraZeneca respiratory business gets boost from 3-drug inhaler results
Yahoo/Reuters
AstraZeneca
Fasenra
Breztri
COPD
Flag link:
Verona hires ex-GSK researchers for late-phase push in COPD
Verona hires ex-GSK researchers for late-phase push in COPD
Fierce Biotech
Verona Pharma
GSK
COPD
R&D
Flag link:
GSK snares top pharma honors at Lions Health with first Grand Prix in years
GSK snares top pharma honors at Lions Health with first Grand Prix in years
Fierce Pharma
advertising
GSK
Cannes Lions Health
COPD
mobile app
Flag link:
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »